Odyssey 2 : A mission toward Neptune and Triton to test General Relativity

Odyssey 2 will be proposed in December 2010 for the next call of M3 missions for Cosmic Vision 2015-2025. This mission, under a Phase 0 study performed by CNES, will aim at Neptune and Triton. Two sets of objectives will be pursued. The first one is to perform a set of gravitation experiments at the Solar System scale. Experimental tests of gravitation have always shown good agreement with General Relativity. There are however drivers to continue testing General Relativity, and to do so at the largest possible scales. From a theoretical point of view, Einstein's theory of gravitation shows inconsistencies with a quantum description of Nature and unified theories predict deviations from General Relativity. From an observational point of view, as long as dark matter and dark energy are not observed through other means than their gravitational effects, they can be considered as a manifestation of a modification of General Relativity at cosmic scales. The scientific objectives are to: (i) test the gravitation law at the Solar System scale; (ii) measure the Eddington parameter; and (iii) investigate the navigation anomalies during fly-bys. To fulfil these objectives, the following components are to be on board the spacecraft: (i) the Gravity Advanced Package (GAP), which is an electrostatic accelerometer to which a rotating stage is added; (ii) radio-science; (iii) laser ranging, to improve significantly the measure of the Eddington parameter. The second set of objectives is to enhance our knowledge of Neptune and Triton. Several instruments dedicated to planetology are foreseen: camera, spectrometer, dust and particle detectors, and magnetometer. Depending on the ones kept, the mission could provide information on the gravity field, the atmosphere and the magnetosphere of the two bodies as well as on the surface geology of Triton and on the nature of the planetary rings around Neptune.Comment: 61st International Astronautical Congress (Prague, Czech Republic - September 2010), 7 page

Drying nano particles solution on an oscillating tip at an air liquid interface: what we can learn, what we can do

Evaporation of fluid at micro and nanometer scale may be used to self-assemble nanometre-sized particles in suspension. Evaporating process can be used to gently control flow in micro and nanofluidics, thus providing a potential mean to design a fine pattern onto a surface or to functionalize a nanoprobe tip. In this paper, we present an original experimental approach to explore this open and rather virgin domain. We use an oscillating tip at an air liquid interface with a controlled dipping depth of the tip within the range of the micrometer. Also, very small dipping depths of a few ten nanometers were achieved with multi walls carbon nanotubes glued at the tip apex. The liquid is an aqueous solution of functionalized nanoparticles diluted in water. Evaporation of water is the driving force determining the arrangement of nanoparticles on the tip. The results show various nanoparticles deposition patterns, from which the deposits can be classified in two categories. The type of deposit is shown to be strongly dependent on whether or not the triple line is pinned and of the peptide coating of the gold nanoparticle. In order to assess the classification, companion dynamical studies of nanomeniscus and related dissipation processes involved with thinning effects are presented

Optical 3D-storage in sol-gel materials with a reading by Optical Coherence Tomography-technique

We report on the recording of 3D optical memories in sol-gel materials by using a non-linear absorption effect. This effect induces a local change of the optical properties of the material which is read and quantified with a high resolution full-field Optical Coherence Tomography setup. It is the first time that this technique is used for this purpose. Data recording was performed by focused picosecond (ps) single-pulse irradiation at 1064 nm with energy densities of 10 and 33 J/cm2 per pulse.Comment: 19 pages, 7 figure

One health, une seule santé

One Health, « Une seule santé », est une stratégie mondiale visant à développer les collaborations interdisciplinaires pour la santé humaine, animale et environnementale. Elle promeut une approche intégrée, systémique et unifiée de la santé aux échelles locale, nationale et mondiale, afin de mieux affronter les maladies émergentes à risque pandémique, mais aussi s'adapter aux impacts environnementaux présents et futurs. Bien que ce mouvement s’étende, la littérature en français reste rare. Traduit de l’anglais, coordonné par d’éminents épidémiologistes et s'appuyant sur un large panel d' approches scientifiques rarement réunies autour de la santé, cet ouvrage retrace les origines du concept et présente un contenu pratique sur les outils méthodologiques, la collecte de données, les techniques de surveillance et les plans d’étude. Il combine recherche et pratique en un seul volume et constitue un ouvrage de référence unique pour la santé mondiale

Hématologie.

Gecorrigeerd via dispense

L’équipe de France en ordre de marche pour conquérir de nouveaux marchés

Dans un marché nucléaire international en pleine croissance où de nouveaux acteurs émergent, la filière nucléaire se met en ordre de marche autour d’un chef de file, EDF, pour apporter une offre adaptée aux besoins des pays qui développent l’énergie nucléaire. Assise sur le triptyque « qualité, innovation, sûreté », la filière porte une ambition : améliorer sa compétitivité pour remporter des appels d’offres à l’export. Pour dessiner une vision et une stratégie communes, EDF, le CEA et AREVA ont créé en mars 2016 la Plateforme France Nucléaire (PFN), une instance tripartite d’échanges sur les principaux sujets transverses de la filière en France et à l’international. Décryptage des ambitions de la filière avec les membres de cette instance: Jean-Bernard Lévy, président-directeur général d’EDF, Philippe Varin, président du conseil d’administration d’AREVA, et Daniel Verwaerde, administrateur général du CEA

Potential Budgetary Impact of Large Scale Screening of Small Fiber Neuropathy in the Follow-Up of Patients with Type 2 Diabetes in France

Aims: The burden of diabetes-related complications is important and increasing in France. Early screening of microvascular complications could avoid the occurrence of more severe consequences. An economic model using a 5-year time horizon was developed to estimate the potential impact in France of large screening of diabetic autonomic neuropathy using Sudoscan, a quick, non-invasive and quantitative method developed for screening of small fiber neuropathy. Methods: A disease progression model was first developed to describe the long-term evolution of patients with type 2 diabetes regarding microvascular complications over successive time periods and patients were classified in 4 groups according to the severity. Complication-related costs were then calculated for a cohort of patients treated according to the current pattern of care and compared with the costs incurred by the same cohort assuming the introduction and widespread use of a large screening of small fiber neuropathy using the Sudoscan method. Comparison of treatment costs between the two situations was used to evaluate the potential budget impact of such a prevention policy in France. Results: According to this general screening of early complications more than 25,000 patients could avoid more severe complications. The gross benefit of such a new prevention strategy would be around € 280 million at 5th year. After 5 years of follow-up, the cumulated gross benefit would be € 837 million and in the worst case scenario (decrease of 20% for each uncertain parameter, namely the distribution of patients among severity groups, the death rates in each severity group, and the distribution of newly diagnosed patients in each severity group) gross benefit would remain at more than € 50 million for the first year and more than € 255 million at the 5th year (using 6% as global efficacy of screening method as basal value). Conclusion: Large screening of small fiber neuropathy could avoid more severe peripheral neuropathy and consequently decrease the burden related to such complications for a limited investment.nonouirechercheInternationa